HQBIO

HQ Bio is a London-based synthetic biology company specializing in the production of high-purity, large-scale synthetic DNA. The company's core technology, the oDNA (optimized DNA) platform, provides an alternative to traditional plasmid DNA, which often faces challenges related to manufacturing complexity and scalability. HQ Bio's approach enables the rapid and cost-effective production of DNA for use in advanced medicinal products, including gene therapies and mRNA vaccines. By addressing the DNA bottleneck, the company seeks to streamline the development and commercialization of next-generation therapeutics. The platform is designed to be modular and scalable, supporting the industry's shift toward more complex and personalized genetic medicines.